Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency

This publication has 53 references indexed in Scilit:

• Acid ceramidase is a novel drug target for pediatric brain tumors
  Oncotarget, 2017
• Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics
  Physiological Genomics, 2014
• A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
  New England Journal of Medicine, 2014
• Ceramide signaling in cancer and stem cells
  Future Lipidology, 2008
• Acid ceramidase and human disease
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 2006
• Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells
  Cancer Research, 2006
• The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts
  The Prostate, 2003
• Ceramide in apoptosis: an overview and current perspectives
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002
• [Anti-tumor effects of carmofur on human 5-FU resistant cells].
  1999
• Antitumor Activity of Fluoropyrimidines and Thymidylate Synthetase Inhibition
  Japanese Journal of Cancer Research, 1991